Oncternal Therapeutics Statistics
Total Valuation
PNTG has a market cap or net worth of $901.38 million. The enterprise value is $1.21 billion.
| Market Cap | 901.38M |
| Enterprise Value | 1.21B |
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PNTG has 34.56 million shares outstanding. The number of shares has increased by 13.00% in one year.
| Current Share Class | 34.56M |
| Shares Outstanding | 34.56M |
| Shares Change (YoY) | +13.00% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 4.68% |
| Owned by Institutions (%) | 78.41% |
| Float | 29.93M |
Valuation Ratios
The trailing PE ratio is 33.79 and the forward PE ratio is 21.63. PNTG's PEG ratio is 1.66.
| PE Ratio | 33.79 |
| Forward PE | 21.63 |
| PS Ratio | 1.09 |
| Forward PS | 1.00 |
| PB Ratio | 2.90 |
| P/TBV Ratio | 22.81 |
| P/FCF Ratio | 37.29 |
| P/OCF Ratio | 21.63 |
| PEG Ratio | 1.66 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.81, with an EV/FCF ratio of 49.92.
| EV / Earnings | 44.98 |
| EV / Sales | 1.51 |
| EV / EBITDA | 23.81 |
| EV / EBIT | 27.91 |
| EV / FCF | 49.92 |
Financial Position
The company has a current ratio of 1.21, with a Debt / Equity ratio of 0.96.
| Current Ratio | 1.21 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 3.01 |
| Debt / FCF | 13.22 |
| Interest Coverage | 7.26 |
Financial Efficiency
Return on equity (ROE) is 11.72% and return on invested capital (ROIC) is 4.59%.
| Return on Equity (ROE) | 11.72% |
| Return on Assets (ROA) | 3.99% |
| Return on Invested Capital (ROIC) | 4.59% |
| Return on Capital Employed (ROCE) | 6.69% |
| Revenue Per Employee | $114,132 |
| Profits Per Employee | $3,832 |
| Employee Count | 7,000 |
| Asset Turnover | 1.18 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PNTG has paid $8.88 million in taxes.
| Income Tax | 8.88M |
| Effective Tax Rate | 23.02% |
Stock Price Statistics
The stock price has decreased by -11.92% in the last 52 weeks. The beta is 1.48, so PNTG's price volatility has been higher than the market average.
| Beta (5Y) | 1.48 |
| 52-Week Price Change | -11.92% |
| 50-Day Moving Average | 25.96 |
| 200-Day Moving Average | 27.16 |
| Relative Strength Index (RSI) | 60.38 |
| Average Volume (20 Days) | 408,649 |
Short Selling Information
The latest short interest is 592,854, so 1.72% of the outstanding shares have been sold short.
| Short Interest | 592,854 |
| Short Previous Month | 736,389 |
| Short % of Shares Out | 1.72% |
| Short % of Float | 1.98% |
| Short Ratio (days to cover) | 1.79 |
Income Statement
In the last 12 months, PNTG had revenue of $798.92 million and earned $26.82 million in profits. Earnings per share was $0.77.
| Revenue | 798.92M |
| Gross Profit | 165.01M |
| Operating Income | 43.23M |
| Pretax Income | 25.78M |
| Net Income | 26.82M |
| EBITDA | 50.67M |
| EBIT | 43.23M |
| Earnings Per Share (EPS) | $0.77 |
Balance Sheet
The company has $14.39 million in cash and $319.57 million in debt, giving a net cash position of -$305.18 million or -$8.83 per share.
| Cash & Cash Equivalents | 14.39M |
| Total Debt | 319.57M |
| Net Cash | -305.18M |
| Net Cash Per Share | -$8.83 |
| Equity (Book Value) | 333.63M |
| Book Value Per Share | 9.01 |
| Working Capital | 22.43M |
Cash Flow
In the last 12 months, operating cash flow was $41.68 million and capital expenditures -$17.51 million, giving a free cash flow of $24.17 million.
| Operating Cash Flow | 41.68M |
| Capital Expenditures | -17.51M |
| Free Cash Flow | 24.17M |
| FCF Per Share | $0.70 |
Margins
Gross margin is 20.65%, with operating and profit margins of 5.41% and 3.36%.
| Gross Margin | 20.65% |
| Operating Margin | 5.41% |
| Pretax Margin | 4.83% |
| Profit Margin | 3.36% |
| EBITDA Margin | 6.34% |
| EBIT Margin | 5.41% |
| FCF Margin | 3.03% |
Dividends & Yields
PNTG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.00% |
| Shareholder Yield | -13.00% |
| Earnings Yield | 2.98% |
| FCF Yield | 2.68% |
Analyst Forecast
The average price target for PNTG is $34.50, which is 32.29% higher than the current price. The consensus rating is "Buy".
| Price Target | $34.50 |
| Price Target Difference | 32.29% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PNTG has an Altman Z-Score of 2.8 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.8 |
| Piotroski F-Score | 7 |